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Abstract: For the European Pharmacopoeia (Ph. Eur.) herbal monograph draft of Cassia angustifolia 
Vahl. and Cassia senna L. leaves and pods, a safety limitation of aloe-emodin and rhein was 
proposed, due to toxicological concerns. A quantitative, analytical method of the anthraquinone 
aglycones in all Ph. Eur. monographed herbal laxatives is of interest. A rational method 
development for the aglycones aloe-emodin, rhein, emodin, chrysophanol, and physcion in five 
herbal drugs was realized by using 3D chromatographic modelling (temperature, solvent, and 
gradient time) and design of experiment (DOE) software (DryLab® 4). A methodical approach 
suitable for the challenging peak tracking in the chromatograms of the herbal drugs in dependence 
on the changes in the chromatographic conditions is described by using a combination of mass 
spectroscopy (MS) data (UHPLC-QDa), UV/Vis-spectra, and peak areas. The model results indicate 
a low robust range and showed that with the selected chromatographic system, small interferences 
could not be averted. The separation achieved shows a pure UV/Vis spectrum for all aglycones 
except for chrysophanol in Aloe barbadensis and emodin in Cassia angustifolia fruit. A gradient with 
the best resolution of the aglycones in all five drugs is proposed, and its suitability demonstrated 
for the quantification of aglycones in these herbal drugs. 
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The concentrated and dried juice of the leaves of Aloe barbadensis Mill., the pods of Cassia angustifolia 
Vahl., the bark of Rhamnus frangula L. and Rhamnus purshianus DC., and the roots of Rheum palmatum L. 
belong to the group anthraquinone containing drugs with laxative properties. All are listed in the 
European Pharmacopoeia (Ph. Eur.). Their laxative effect is based on the anthraquinone glycosides 
or dianthron glycosides. The metabolism is not well studied but the anthraquinone glycosides or 
dianthron glycosides are split by colonic bacteria into the free and biologically active aglycones [1]. 
Depending on the plant species, these anthraquinone aglycones are aloe-emodin, rhein, emodin, 
chrysophanol, and/or physcion (Figure 1). On the one hand, these aglycones exert numerous 
biological effects and potentially other effects relevant to pharmacology, for example, anticancer, 
anti-inflammatory, and antifungal effects [2–5]. On the other hand, aloe-emodin and emodin show 
Molecules 2017, 22, 1838 2 of 12 
 
some genotoxic effects in vitro [6–9] which were not visible in vivo (aloe-emodin) [6,10,11] or herbal 
extracts [12–15]. However, a limitation of aloe-emodin and rhein was proposed in the herbal 
monograph draft for Cassia angustifolia Vahl. and Cassia senna L. leaves and pods [16]. In light of a 
potential limitation in Cassia, the aglycone content used in other herbal laxatives would be of interest, 
which leads to the demand for a quantitative analytical method to review the aglycones in all 
considered herbal laxatives. 
 
Figure 1. Chemical structure of the anthraquinone aglycones: aloe-emodin, rhein, emodin, chrysophanol, 
and physcion. 
For the five aglycones, aloe-emodin, rhein, emodin, chrysophanol and/or physcion, numerous 
high performance liquid chromatography (HPLC) methods have been published for different species, 
i.e., Cassia sp. [17,18] (HPLC-ultraviolet detection), Rheum sp. [19–22] (HPLC photodiode array detector, 
HPLC-DAD), Polygoni sp. [23] (HPLC-fluorescence detection), and Rhamnus sp. [24–26] (HPLC-DAD). 
They all differ markedly in the sample preparation, calibration range, mobile and stationary phases, 
and are, therefore, not a basis for a reliable comparison concerning the distribution and content of the 
aglycones in the different herbal drugs of interest. Instead of testing all mentioned methods for all 
the five herbal drugs, a new systematic development approach was chosen. In this report, the 
development of an UHPLC-DAD method is presented by using 3D chromatographic modelling 
(temperature, solvent, and gradient time) and design of experiment (DOE) software (DryLab® 4) with 
12 variated measuring points. The model calculates multi-dimensional resolutions through which the 
conditions for a baseline separation can be elucidated. The interferences for the peaks of interest are 
taken into account by using mass spectroscopy (MS) data for peak tracking in the 12 different input 
chromatograms. This approach for peak tracking, in combination with chromatographic modeling 
software, leads to the possibility of developing a fast separation in highly complex samples with 
unknown substances within the set boundaries (pH, stationary phase, solvents). To the best of our 
knowledge, no method development for these anthraquinone aglycones in all five herbal drugs has 
been performed with DryLab®. For the anthraquinone aglycones in rhubarb, a method development 
with DryLab® scouting runs was presented by Liu et al. [22], however, the methodological approach 
presented in this report differs markedly. 
2. Results and Discussion 
The most important step for a successful model is the peak tracking of each peak in all 12 input 
runs. In the case of the reference substances, this is easily achieved. The substances of interest can be 
injected in pure form, or a mixture with different concentrations of each substance can be used. The 
second method leads to the risk of difficulties in peak tracking when multiple substances co-elute. 
However, the aglycones can be easily distinguished due to their mass in combination with the used 
concentration. The aglycone pairs aloe-emodin and emodin, as well as rhein and physcion, share the 
same molecular mass. Therefore, higher concentrations were used for aloe-emodin and rhein.  
A baseline separation was given for the aglycones in ten input runs (Figure 2). Only aloe-emodin and 
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rhein co-eluted with the short gradient (tg1) and acetonitrile as the organic modifier. With the use of 
methanol, the retention time of all aglycones increased for roughly 2–3 min and the critical peak pair, 
meaning the pair with the least resolution, shifted from aloe-emodin and rhein to emodin and 
chrysophanol. The higher temperature increased the elution for roughly 1 min. The aglycones were 
separated in most conditions and the elution order remained the same in all conditions. However, 
based on visual examination, the best and most even separation was achieved with the condition tg2 
and the mixture of acetonitrile (ACN)/MeOH as an organic modifier (highlighted in Figure 2). 
Therefore, this condition was chosen as a starting point to determine the interfering peaks from the 
herbal drugs. 
In the chromatograms of the herbal drugs, the purity of the aglycone peaks were verified by 
UV/Vis spectra at multiple points within the peak. If all peaks were pure, the peaks close to the 
aglycones were chosen and the m/z-ratio for the base peak in the MS-trace (either positive or negative 
scan) was determined. Thereafter, the chromatograms at that specific m/z ratio were derived for the 
further eleven input runs in order to determine the retention time of the desired peak. When the peak 
in the other input runs was pure, the identity was checked for plausibility by comparing the UV/Vis-
spectra. This procedure was repeated for all peaks of interest from the plant samples. In Figure 3,  
the chromatograms derived from 435 nm of Aloe barbadensis Mill. and Rheum palmatum L. roots are 
shown in the chosen starting point (T2, tg2, mixture of B1 and 2). The retention times of the six peaks, 
indicated with an arrow, were derived from all input runs by this method. Peaks around the 
aglycones, as well as peaks eluting at the beginning of the chromatogram, were chosen for the model 
to create a prediction for the whole herbal matrices. After completing the peak tracking process by 
this method, 13 additional peaks from the herbal matrices were implemented in the model; three 
substances from Aloe barbadensis Mill., three from Rheum palmatum L., three from Rhamnus frangula L., 
one from Rhamnus purshianus DC., and three substances from Cassia angustifolia Vahl. The retention 
times of many peaks in the 12 runs were tracked and identified by using this approach. However, 
there are limitations. Substances which are not ionisable, have no characteristic m/z-profile or unique 
mass, as well as peaks which are unseparated in all the input runs, cannot be tracked unless the peak 
area allows a clear identification in all input runs. Also, for small peak areas, difficulties occur with 
the peak verification by UV/Vis-spectra. 
Moreover, not all peaks need peak tracking for a successful model prediction. With the 13 peaks 
from the herbal matrices and the five peaks from the aglycones, a resolution cube with one million 
chromatograms (100 at each axis of the cube) for a one-step gradient was calculated. The working 
areas with a resolution ≥1.5 for the critical peak pairs (pair with the lowest resolution per condition) 
are shown in Figure 4, left. The model output elucidates a very narrow robust range for the separation 
of the aglycones in all five drugs. The working space with the highest robustness was predicted to be 
with 22% MeOH/78% ACN as an organic modifier, a temperature of between 30 and 35 °C, and a 
linear gradient of around 35 min (red area in Figure 4, right). From this linear gradient at a 
temperature of 30 °C, five gradients were manually optimized within the software to obtain a faster 
and more precise separation in the aglycones area. The predicted retention times and chromatograms 
were in good correlation with the ones measured. Additionally, the suitability of the model was shown 
with sennosides and aglycones in a previous work with Cassia under very similar chromatographic 
conditions [27]. 
The five gradients chosen had a run-time of between 13.5 and 19 min (Figure 5) with a predicted 
minimal resolution >1.8 for the critical peak pair. For the critical peak pair, substances other than the 
aglycones were selected to obtain a maximal resolution in the area of the aglycones. The selected 
gradients differed in the starting concentration of the organic modifier (35 to 46% B), the onset time, 
and gradient slope, as well as in the number of gradient steps. For the test runs, all herbal samples 
were freshly prepared with a tenfold increase in ratio of drug to extraction solvent (DSR of 100 mg 
per 1 mL) due to the low content of aglycones in the drugs which resulted in small peaks. 
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 B1 = acetonitrile B1 & 2 (50:50 v/v) B2 = methanol
T1 = 30 °C 
tg1 = 10 min 
 
T2 = 50 °C 
tg1 = 10 min 
 
T1 = 30 °C 
tg2 = 30 min 
 
T2 = 50 °C 
tg2 = 30 min 
 
Figure 2. Chromatograms of reference substances aloe-emodin, rhein, emodin, chrysophanol, and physcion for the 12 input runs at 435 nm. tg1: time of gradient 1 (10 min 
from 1 to 99% B), tg2: time of gradient 2 (30 min from 1 to 99% B) 
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Figure 3. Chromatograms of Aloe barbadensis Mill. and Rheum palmatum L. roots at 435 nm with 
conditions T2 (50 °C), tg2 of 30 min, and organic modifier acetonitrile (ACN)/MeOH 50:50 (v/v). 
Arrows indicate the peaks which were added to the DryLab® model after successful tracking in all 
input runs. The chromatograms of these two species were chosen as an example to illustrate the peaks 
added to the model from the herbal matrix. In the other species, fewer peaks close to the aglycones 
were added to the model. 
 
(a) (b)
Figure 4. (a) Calculated resolution cube showing the working points with a resolution ≥1.5 for the 
critical peak pair of the 18 peaks subjected to the model. (b) Graphical view of the peak resolution in 
a cross section of the organic eluent acetonitrile/methanol (78:22 v/v) as a function of the temperature 
and gradient time. Color scale shows the predicted resolution of the critical peak pair. 
The obtained data from the test runs was evaluated in three steps. The first evaluation was for 
peak separation and purity of the peaks. Therefore, the UV/Vis spectra of the aglycones in the herbal 
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samples were analyzed by screening through each peak and studying the peak spectra at the apex, 
inflections, and valleys. The resulting amount of impure, or not well separated, peaks was counted 
for each method (Figure 6). As a second approach, the purity of the m/z-ratio was studied for each 
aglycone peak as the amount of m/z—impurities could differ compared to the ones from the UV/Vis 
spectra due to the underground matrix present in some samples. Lastly, the number of misidentified 
peaks from the processing step with the software was studied for each herbal sample in order to test 
the separation for multi-herbal analysis. The sum of those parameters is shown in Figure 6. No 
gradient tested showed a perfect resolution for all aglycones in all samples.  
 
Figure 5. Selected gradients at working point 22% MeOH in ACN as an organic modifier and column 
temperature of 30 °C. 
 
Figure 6. Sum of aglycone peak impurities and misidentified peaks per gradient tested. Each impurity 
or misidentified aglycone peak was counted as one deficit of the gradient tested.  
The ideal method was considered to have no impurities in the aglycone peaks and no wrongly 
integrated peaks, meaning no co-eluting substances in all tested herbals allowing for a multi-drug 
analysis. No gradient tested fulfilled these demands. An addition of further interfering peaks to the 
model would yield no additional optimizations for the separation due to the already very small 
robust range of the model (Figure 7). Therefore, gradient 1 was chosen as the best fitting method as 
this gradient showed the least amount of impurities. The resolutions of the aglycones for the five 
investigated gradients are shown in Table 1 for the reference solution mix and the five herbal samples 
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investigated. The resolutions are not shown for all peak pairs. Small peaks (height down to 0.0003 AU) 
were considered that showed an inadequate peak shape, meaning the inflections were not detectable, 
or no baseline separation. Therefore, the width at a peak height of 50% was not derivable for all peaks, 
which made the calculations impossible for some peak pairs (indicated as n/a). The height chosen for 
the integration correlates with the limit of detection based on signal-to-noise ratio the (S/N) of 
gradient 3. The peak pairs investigated showed strong differences in peak height and also varied in 
their symmetry. Therefore, the resolutions have to be regarded cautiously. Nevertheless, gradient 1 
showed, overall, the best resolutions and no impurities for aloe-emodin.  
 
Figure 7. Chromatograms at 435 nm with the selected gradient 1 of the five drug samples (drug solvent 
ratio 100 mg:1 mL) (A) dried leaf juice of Aloe barbadensis Mill. (with detailed view: 7.5–17 min);  
(B) bark of Rhamnus purshianus DC. (with detailed view: 9–17 min); (C) bark of Rhamnus frangula L.; 
(D) roots of Rheum palmatum L.; (E) pods of Cassia angustifolia. 
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Table 1. Resolution of the aglycones in each sample for the five investigated gradients. The resolution 
was calculated manually at 50% width and small peaks (>0.0003 AU) were considered for the calculation 
of the resolution. 
 Gradient 1 Gradient 2 Gradient 3 Gradient 4 Gradient 5
Reference 
solutions 
AE      
R 7.19 6.48 7.88 8.73 6.06 
E 29.33 27.79 28.22 25.66 27.23 
C 17.66 17.18 18.85 18.31 16.39 
P 11.97 9.97 11.47 12.85 9.70 
A. barbadensis 
AE 2.22 impure n/a n/a 1.74 
C n/a impure impure 2.22 n/a 
R. purshianus 
AE 1.44 n/a 2.36 2.15 1.73 
E 4.51 4.17 5.25 4.91 n/a 
C 1.97 impure 2.19 3.07 impure 
P 1.65 n/a 1.70 1.20 n/a 
R. frangula 
E n/a n/a n/a n/a 5.52 
C 4.76 n/a 4.97 5.05 n/a 
P 2.49 n/a impure n/a n/a 
R. palmatum 
AE 2.68 2.75 2.65 impure impure 
R 5.31 4.84 n/a n/a 4.12 
E 4.13 4.65 5.59 n/a impure 
C 3.26 3.52 3.17 13.08 2.68 
P impure impure impure impure impure 
C. angustifolia 
AE 2.77 1.41 n/a n/a 2.76 
R 5.65 5.12 n/a impure 5.28 
E 2.10 impure 1.70 1.88 impure 
C impure 2.27 impure impure 1.73 
AE: aloe-emodin, R: rhein, E: emodin, C: chrysophanol, P: physcion, n/a: peak height too small and/or 
separation insufficient to derive width, impure: co-elution, not calculated. 
Gradient 1 showed the best results with only two minor impurities in the aglycone area: one due 
to the underground matrix in Aloe barbadensis interfering with chrysophanol and the second an 
impurity for emodin (shoulder in UV/Vis spectra at 388 nm) in Cassia angustifolia. Due to the low 
content of aglycones, as well as to the underground matrix, additional peaks in the m/z—ratio were 
visible, and small peaks are misidentified at the retention time of aglycones in all herbals except 
Rhamni purshiani and Rheum palmatum. The misidentified peaks are rather small (2/3 have a peak 
height <0.001 AU) and are, therefore, considered to be a minor interference of the aglycones (general 
peak height of 0.1 to 0.6 AU). Hydroxyanthracene glycosides as well as other polar substances are 
flushed through the column and elute between 1 and 3 min, as can be seen in Figure 7. The elution of 
the aglycones starts with aloe-emodin at 6 min and ends with physcion at 14.9 min. The elution of 
emodin was prolonged to allow a separation from rhein of the two peaks in Rhamnus frangula L. 
between rhein and emodin (frangulin A and B). Overall, with gradient 1 (0/43, 8/43; 12/65; 15/99; 
16.5/99 (min/%B)) the separation of the aglycones was very good in all samples. The main 
disadvantage is the impurities due to the background matrix especially in Aloe barbadensis (retention 
time 9 to 16 min) but also slightly in Rhamni purshiani which is only removable through changes in 
sample preparation. 
3. Materials and Methods 
For the development, a method for anthraquinone glycosides and aglycones in the bark of 
Rhamnus frangula served as a basis in terms of sample preparation, choice of pH condition, and 
considered solvents for the model [28,29]. 
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3.1. Chemicals 
Aloe-emodin (>96%, Lot. No. 6479), emodin (>92%, Lot. No. 8668), and physcion (>98%, Lot. No. 
2910) were purchased from PhytoLab GmbH & Co. KG (Vestenbergsgreuth, Germany). Rhein (>98%, 
Lot. No. SLBC4285V) and chrysophanol (>99%, Lot. No. BCBL2252V) were obtained from  
Sigma-Aldrich (Buchs, Switzerland). Acetonitrile and methanol used were of MS grade (Merck, 
Darmstadt, Germany) as was formic acid (Carlo Erba Reagents S.r.l., Cornaredo, MI, Italy). Dimethyl 
sulfoxide (DMSO) was of pure quality (>99%, Sigma-Aldrich, Buchs, Switzerland). Water was of 
purified quality (Arium® pro VF, Sartorius Stedim Siotech S.A., Tagelswangen, Switzerland). 
3.2. Standard Solutions 
Emodin was dissolved to 0.15 mg/mL in methanol. Aloe-emodin and rhein were dissolved to  
0.3 mg/mL and physcion to 0.15 mg/mL in methanol/dimethyl sulfoxide (9:1 v/v). A higher amount 
of DMSO was necessary to obtain a clear solution of 0.15 mg/mL for chrysophanol (methanol/ 
dimethyl sulfoxide (6:4 v/v)). The solutions were mixed for the injection as follows: 3 parts aloe-
emodin, 2 parts rhein, 1 part emodin, 1 part chrysophanol, and 1 part physcion, resulting in a final 
concentration of 112.5 mg/L for aloe-emodin, 75 mg/L for rhein, and 18.75 mg/L for emodin, physcion, 
and chrysophanol. 
3.3. Plant Material and Sample Preparation 
Aloe barbadensis (Lot. No. 0032/1-5-2 F2), Rhamni purshiani bark (Lot. No. 23391), and Rheum 
palmatum roots (Lot. No. 23391) were provided by Alfred Galke GmbH (Bad Grund, Germany). 
Rhamnus frangula bark (Lot. No. 136255) and Cassia angustifolia pods (Lot. No. 131352) were provided 
by DIXA AG (St. Gallen, Switzerland). One hundred milligrams respectively 1.0 g of the ground plant 
material were dispersed in 10 mL acetonitrile/0.2% sodium hydrogen carbonate (68:32 v/v) in volumetric 
glass flasks (25 mL) and sonicated for 20 min at 35–40 °C. After cooling down to room temperature, 
the extract was adjusted to the mark with acidified water (pH 2 by o-phosphoric acid, 85%) and 
filtered over Chromafil® PET 20/25 (0.2 µm pore size, Machery-Nagel AG, Oensingen, Switzerland) 
into brown glass vials. 
3.4. Equipment and Fixed Chromatographic Conditions 
An Acquity classic UHPLC system (VDwell: 0.145 mL) with Empower 3 software was used for 
the separations (Waters AG, Baden, Switzerland) consisting of the following modules: Sample 
Manager, Column Manager, Binary Solvent Manager, PDA eλ Detector (200–500 nm, bandwidth 1.2 nm), 
Isocratic Solvent Manager and QDa Detector (ESI±, cone: 15 V, capillary: 0. 8kV, 150 to 850 m/z). The 
development was performed on ACQUITY UPLC HSS T3 column (1.8 µm, 2.1 × 100 mm,  
S/N 01463312815724) with a flow rate of 0.3 mL/min. After the column, a splitter was installed in the 
Isocratic Solvent Manager which transports 9/10 of the eluate to the PDA detector and 1/10 to the 
QDa Detector mixed with 0.2 mL/min makeup solvent of acetonitrile/water/formic acid (50:50:0.05 
v/v/v). The injection volume was 5 µL. 
3.5. Model Parameters 
The DryLab® 4 software (version 4.2.0.3, Molnár-Institute, Berlin, Germany) uses algorithms 
based on thermodynamic models of the chromatographic process and is well-established for the 
optimization of complex chromatographic procedures. The commercially available software is 
suitable for the Quality by Design (QbD) approach and validations of the model have been carried 
out by the Molnár Institute (distributor of the model) and through its use world-wide [30–32]. 
The model needs retention data from so called “input-runs”. Depending on the model, two, four 
or twelve runs under certain conditions have to be collected prior to using the software. The ternary 
model was chosen for the development, which means the parameters gradient slope (tg), column 
temperature (T), and composition of the organic modifier (B) were varied for the input runs. Formic 
acid (0.1% v/v) was added to all mobile phases which allowed for a model independent from pH 
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changes due to the gradient. Also, a lower pH is beneficial for the separation and peak form due to 
ionization suppression of the carboxyl group of rhein. The gradients were run from 1% organic modifier 
(B) to 99%. Water with 0.1% formic acid was used as a weak solvent (A). Two gradient times (tg) were 
applied (tg1 with 10 min and tg2 with 30 min), as well as two input temperatures (T1 with 30 °C and 
T2 with 50 °C). The design of the input parameters resulting in the twelve runs can be seen in Figure 8. 
 
Figure 8. Design of experiment for the model of temperature (T), gradient time (tg), and organic 
modifier (B1–2). ACN: acetonitrile; MeOH: methanol; B1 and 2: mixture of both 50:50 v/v, all solvents 
with addition of 0.1% formic acid. 
4. Conclusions 
The methodical approach of combining the chromatographic modelling and DOE software 
(DryLab® 4) with UHPLC-QDa proved to be very helpful in developing a gradient method for 
aglycones in five herbal drugs in as short a time as possible. The peak tracking for the unknown 
herbal substances worked for almost all peaks of interest and were relevant for the model by using 
the chromatogram with the best resolution as a starting point and the m/z-ratio in the other input 
runs. The changes of the retention time of each peak within the 12 input runs are also very useful for 
a general verification of a substance’s presence in a complex herbal mixture, i.e. small peak areas of 
the substances lead to unreliable UV/Vis-spectra. The presented approach is a fast way of showing 
the limits of a selected chromatographic system in the optimization process, which is very useful for 
rational UHPLC development in complex herbal mixtures. The robust range of the presented model 
showed that a perfect method is not possible by using the selected chromatographic system, as small 
interferences could not be averted. Nevertheless, the separation achieved shows a pure UV/Vis spectrum 
for all aglycones except for chrysophanol in Aloe barbadensis and emodin in Cassia angustifolia fructus.  
As the interferences are very low in their signal intensity compared to the major aglycone peaks, the 
method is still suitable for the quantification of aglycones in herbal mixtures with adequate errors 
computation. The risk of other interfering substances is still a possibility as only one herbal sample 
per herbal drug was used for the study. The approach presented could be optimized by using a blend 
of different batches per herbal drug and/or a blend of all herbs of interest as, for example, batches 
from different geographic origins or different plant parts. The method presented still needs validation 
in terms of robustness, linearity, accuracy, and precision which will be presented in another report. 
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